260 related articles for article (PubMed ID: 38674936)
1. Treatment of Cachexia in Gastric Cancer: Exploring the Use of Anti-Inflammatory Natural Products and Their Derivatives.
Loyala JV; Down B; Wong E; Tan B
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674936
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide for managing cancer cachexia.
Reid J; Mills M; Cantwell M; Cardwell CR; Murray LJ; Donnelly M
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD008664. PubMed ID: 22513961
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated malnutrition.
Argilés JM
Eur J Oncol Nurs; 2005; 9 Suppl 2():S39-50. PubMed ID: 16437757
[TBL] [Abstract][Full Text] [Related]
4. Cancer Cachexia: Cause, Diagnosis, and Treatment.
Mattox TW
Nutr Clin Pract; 2017 Oct; 32(5):599-606. PubMed ID: 28825869
[TBL] [Abstract][Full Text] [Related]
5. Inflammation in cancer cachexia: to resolve or not to resolve (is that the question?).
Seelaender M; Batista M; Lira F; Silverio R; Rossi-Fanelli F
Clin Nutr; 2012 Aug; 31(4):562-6. PubMed ID: 22348869
[TBL] [Abstract][Full Text] [Related]
6. Iron overload is related to muscle wasting in patients with cachexia of gastric cancer: using quantitative proteome analysis.
Zhou D; Zhang Y; Mamtawla G; Wan S; Gao X; Zhang L; Li G; Wang X
Med Oncol; 2020 Nov; 37(12):113. PubMed ID: 33196891
[TBL] [Abstract][Full Text] [Related]
7. Multitargeted treatment of cancer cachexia.
Madeddu C; Maccio A; Mantovani G
Crit Rev Oncog; 2012; 17(3):305-14. PubMed ID: 22831161
[TBL] [Abstract][Full Text] [Related]
8. Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials.
Molfino A; Amabile MI; Giorgi A; Monti M; D'Andrea V; Muscaritoli M
Expert Opin Investig Drugs; 2019 Aug; 28(8):733-740. PubMed ID: 31347405
[No Abstract] [Full Text] [Related]
9. Inflammatory burden and amino acid metabolism in cancer cachexia.
Durham WJ; Dillon EL; Sheffield-Moore M
Curr Opin Clin Nutr Metab Care; 2009 Jan; 12(1):72-7. PubMed ID: 19057191
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Cancer Cachexia: The Role of Nutritional Interventions.
Mitchell T; Clarke L; Goldberg A; Bishop KS
Healthcare (Basel); 2019 Jul; 7(3):. PubMed ID: 31323984
[TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory drugs for treatment of cancer cachexia: A systematic review.
Bowers M; Cucchiaro B; Reid J; Slee A
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2473-2497. PubMed ID: 37750475
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of GLIM-defined malnutrition in combination with hand-grip strength or gait speed for the prediction of postoperative outcomes in gastric cancer patients with cachexia.
Li ZZ; Yan XL; Zhang Z; Chen JL; Li JY; Bao JX; Ru JT; Wang JX; Chen XL; Shen X; Huang DD
BMC Cancer; 2024 Feb; 24(1):253. PubMed ID: 38395798
[TBL] [Abstract][Full Text] [Related]
13. Update on the treatment of cancer cachexia.
Nishie K; Nishie T; Sato S; Hanaoka M
Drug Discov Today; 2023 Sep; 28(9):103689. PubMed ID: 37385369
[TBL] [Abstract][Full Text] [Related]
14. The Role of Natural Products in the Improvement of Cancer-Associated Cachexia.
Han Y; Kim HI; Park J
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240117
[TBL] [Abstract][Full Text] [Related]
15. Systemic inflammation, cachexia and prognosis in patients with cancer.
Deans C; Wigmore SJ
Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):265-9. PubMed ID: 15809528
[TBL] [Abstract][Full Text] [Related]
16. BPC157 as Potential Agent Rescuing from Cancer Cachexia.
Kang EA; Han YM; An JM; Park YJ; Sikiric P; Kim DH; Kwon KA; Kim YJ; Yang D; Tchah H; Hahm KB
Curr Pharm Des; 2018; 24(18):1947-1956. PubMed ID: 29898649
[TBL] [Abstract][Full Text] [Related]
17. Nutritional support for malnourished patients with cancer.
Baldwin C
Curr Opin Support Palliat Care; 2011 Mar; 5(1):29-36. PubMed ID: 21326001
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of natural products in inflammation: underlying molecular mechanisms, clinical outcomes, technological advances, and future perspectives.
Gouda NA; Alshammari SO; Abourehab MAS; Alshammari QA; Elkamhawy A
Inflammopharmacology; 2023 Dec; 31(6):2857-2883. PubMed ID: 37950803
[TBL] [Abstract][Full Text] [Related]
19. Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial.
Solheim TS; Laird BJA; Balstad TR; Bye A; Stene G; Baracos V; Strasser F; Griffiths G; Maddocks M; Fallon M; Kaasa S; Fearon K
BMJ Support Palliat Care; 2018 Sep; 8(3):258-265. PubMed ID: 29440149
[TBL] [Abstract][Full Text] [Related]
20. The anti-wasting effects of L-carnitine supplementation on cancer: experimental data and clinical studies.
Esfahani M; Sahafi S; Derakhshandeh A; Moghaddas A
Asia Pac J Clin Nutr; 2018; 27(3):503-511. PubMed ID: 29737795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
